BioTransfer Award 2012

Organized by the Fondation Biotech Montréal, this BioTransfer Awards event, which took place on December 6, 2012, celebrates the excellence of technologies that were presented at the Crossroad for BioTransfer 2012 on May 29, 2012 at the National Research Council.

The members of the selection committee were Nicola Urbani, then Vice-President of the Board, AgeChem Finances; Youssef Bennani, Site Head and VP R&D, Vertex Pharmaceuticals; Mario Fillion, Executive Vice-President and Chief Scientific Officer, Alethia Biotherapeutics; Philippe Crine, Professor of Biochemistry, Université de Montréal and Co-Founder of Enobia as well as Benoît Tremblay, Director General, Fondation Biotech Montréal.

Présentateur à BioTransfert 2011

Two prizes were awarded during the evening:

The Gervais-Dionne Award, which rewards the most promising technology, was awarded to Dr. Maureen O’Connor-McCourt, from the National Research Council Canada, for her technology called New Cancer Targets and Matching Antibodies for Diagnostic and Therapeutic Use and presented on May 29, 2012 at the Crossroad for BioTransfer.

The great potential of this technology has attracted the attention of three Canadian SMEs thus far, with Toronto-based biotech firm AvidBiologics Inc leading the pack. Indeed, AvidBiologics announced the signing of an agreement with NRC in late January to develop three antibody-drug conjugates for the treatment of cancer.

“We are privileged to have concluded this agreement with the (NRC),” said the company’s chairman, David Allen, in a news release. “In its brief period of existence, AvidBiologics has made significant advances in its programs through its partnership with the NRC and access to (its) advanced protein-engineering capabilities. We anticipate that this agreement will be a showcase for the value of public-private partnerships.”

Maureen O'connor

Dr. Maureen O’Connor-McCourt from the National Research Council Canada, receiving her award from François Schubert, President of the Fondation Biotech Montréal.

The Fondation Biotech Montréal Award honoring the person having given the Best Business Presentation was awarded to Dr. Patrick Williams from McGill University, for his technology called GIFT-21 - targeted cancer immunotherapy .

Patrick Williams

Dr. Patrick Williams from McGill University, receiving his award from Benoît Tremblay, Director General of the Fondation Biotech Montréal.